Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Revenues
Product sales - net	$ 1,820,979	$ 1,877,932	$ 3,939,140
Service and repair fees - net	9,549,316	10,082,631	10,841,935
Service and repair fees - related parties - net	110,000	110,000	110,000
Patient revenue - net of contractual allowances and discounts	28,153,598	24,307,192	7,481,865
Provision for bad debts for patient fee	12,770,249	10,333,082	2,584,669
Management and other fees - net	34,805,627	34,839,969	21,493,599
Management and other fees - related medical practices - net	7,381,725	7,620,835	7,859,944
Total Revenues - Net	69,050,996	68,505,477	49,141,814
Costs and Expenses
Costs related to product sales	1,882,230	1,067,120	3,656,635
Costs related to service and repair fees	2,189,373	2,496,985	3,213,420
Costs related to service and repair fees -related parties	25,220	27,242	32,603
Costs related to patient fee revenue	7,939,524	7,670,484	2,704,758
Costs related to management and other fees	20,970,116	20,851,065	12,998,243
Costs related to management and other fees - related medical practices	5,397,818	5,134,553	3,515,706
Research and development	1,812,398	1,760,821	1,438,560
Selling, general and administrative, inclusive of compensatory element of stock issuances of $53,200, $223,000 and $415,021, for the years ended June 30, 2015, 2014 and 2013, respectively	13,459,408	15,388,239	12,501,621
Provision for bad debts	2,475,032	1,806,299	1,544,521
Total Costs and Expenses	56,151,119	56,202,808	41,606,067
Income from Operations	12,899,877	12,302,669	7,535,747
Other Income and (Expenses):
Interest expense	702,095	884,541	500,362
Investment income	225,270	238,928	217,598
Other income (expense) - net	394,810	(608,599)	725,488
Income before benefit (provision) for income taxes and noncontrolling interests	12,817,862	11,048,457	7,978,471
Benefit for Income Taxes	2,612,521	2,348,312	2,277,891
Net Income	15,430,383	13,396,769	10,256,362
Net Income - Noncontrolling Interests	2,519,732	3,000,639	1,577,820
Net Income - Attributable to FONAR	$ 12,910,651	$ 10,396,130	$ 8,678,542
Basic Net Income Per Common Share Available to Common Stockholders	$ 2.13	$ 1.73	$ 1.46
Weighted Average Basic Shares Outstanding - Common Stockholders	6,050,632	6,009,822	5,933,318
Common Stock
Other Income and (Expenses):
Net Income - Attributable to FONAR	$ 12,071,670	$ 9,720,030	$ 8,107,367
Basic Net Income Per Common Share Available to Common Stockholders	$ 2.00	$ 1.62	$ 1.37
Diluted Net Income Per Common Share Available to Common Stockholders	$ 1.95	$ 1.58	$ 1.34
Weighted Average Basic Shares Outstanding - Common Stockholders	6,050,632	6,009,822	5,933,318
Weighted Average Diluted Shares Outstanding - Common Stockholders	6,178,136	6,137,326	6,060,822
Class A Non Voting Preferred Stock
Other Income and (Expenses):
Net Income - Attributable to FONAR	$ 625,309	$ 503,911	$ 425,708
Class C Common Stock
Other Income and (Expenses):
Net Income - Attributable to FONAR	$ 213,672	$ 172,189	$ 145,467
Basic Net Income Per Common Share Available to Common Stockholders	$ 0.56	$ 0.45	$ 0.38
Diluted Net Income Per Common Share Available to Common Stockholders	0.56	0.45	$ 0.38
Basic and Diluted Income Per Share - Common C	$ 0.44	$ 0.45
Weighted Average Basic Shares Outstanding - Common Stockholders	382,513	382,513	382,513
Weighted Average Diluted Shares Outstanding - Common Stockholders	382,513	382,513	382,513
Weighted Average Basic and Diluted Shares Outstanding - Class C Common	382,513	382,513	382,513